Management of HCV transplant patients with triple therapy. - Wikidata - awgldk - TriplyDB

Management of HCV transplant patients with triple therapy.

Management of HCV transplant patients with triple therapy.

http://www.wikidata.org/entity/Q38174249

about

Hepatitis C: New challenges in liver transplantation Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?Management of viral hepatitis in liver transplant recipients Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy.Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Predictive factors associated with hepatitis C antiviral therapy response.Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation Provision of clinical pharmacist services for individuals with chronic hepatitis C viral infection: Joint Opinion of the GI/Liver/Nutrition and Infectious Diseases Practice and Research Networks of the American College of Clinical Pharmacy.Management of post transplant hepatitis C in the direct antiviral agents era.Tolerability and effectiveness of sofosbuvir and simeprevir in the post-transplant setting: systematic review and meta-analysis.Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C.

P2860

Q26999368-792B5108-8718-475C-A4EE-A7742A91377D Q33426112-58615C56-45FA-4B3E-A0D1-CD27B913F205 Q34779730-F6FDB342-76A7-4B24-A8DE-7A648BADC801 Q35214724-E1106CC8-0153-426F-B065-FA25D861CA59 Q35384561-507E40CE-D674-4502-BB12-E9132341796A Q35790393-D457AA6E-2CC0-4092-A6CB-1D2F9A8130D8 Q35790397-80AF1831-FD8A-45FE-8A0F-740343F82CC2 Q36241697-10479254-1231-4C57-98CA-FA0A45312C12 Q38264060-9EDB08AF-E0EB-4A17-8D96-D636B143A235 Q38395275-33FC8D2E-4C87-44E8-8EC5-1B1F97299C03 Q38769679-C8729FDF-89AB-4FEC-9B68-1EF6D46071B9 Q40107697-46C64495-8D43-4421-B048-F416E99437E1 Q42233093-7ECE9E46-9EFF-421C-A2F2-3F52755A1FD4

P2860

Management of HCV transplant patients with triple therapy.

http://www.wikidata.org/entity/Q38174249

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Management of HCV transplant patients with triple therapy.

@en

type

label

Management of HCV transplant patients with triple therapy.

@en

prefLabel

Management of HCV transplant patients with triple therapy.

@en

P1433

Q38174249-A4D78D85-95C4-4B2C-BDE1-C00A87CEFCD1

P1476

Q38174249-CA0DB595-A763-48BE-BAFA-CD1FD60923DC

P2093

Q38174249-781A8387-81C8-4231-94C8-34A3A73A4D95

Q38174249-CE39E3F7-91B2-408D-BFB3-618A5055FDFA

P2860

Q38174249-038EB4B3-9FDC-402F-BC51-245DAAB18FC4

Q38174249-07BDBE1E-26D8-455F-BF9E-35A4C0296225

Q38174249-10E5E30A-7D09-4E68-84A6-8673AAAB9034

Q38174249-12164B5F-388C-4A8B-B0F4-48E35893C52E

Q38174249-14144F7C-F422-4B24-9E69-6FAFB3235E33

Q38174249-14B1E21B-ECB1-465B-ADD4-1136567DFA53

Q38174249-15C37007-066A-4DD4-853A-0286F67FEB1E

Q38174249-1ED0D9CD-0DAE-4806-9553-5713A6931274

Q38174249-2089A01E-43F0-4FAE-8F57-91A4D3647B49

Q38174249-20DB8D9D-FB7D-4340-B9EB-55F37DF8B240

P304

Q38174249-32ED598E-D8BC-4580-8EDD-23AED9E50347

P31

Q38174249-A9C771F2-AA59-431D-B2E8-1DDC63CB8C07

P356

Q38174249-E0BC2653-50EB-4EEE-8148-3F88B354A42C

P478

Q38174249-3031DB7A-43BC-4B5C-B3BE-F9985AEBE460

P50

Q38174249-9BBC1C6E-C106-4014-9923-49EC75D5AD3B

Q38174249-C6268AF2-0D8C-4119-B766-582EC4219F02

P577

Q38174249-B4A44AB8-986F-4C05-9C80-253D79DCFC92

P5875

Q38174249-AA059B17-B75A-4D8D-961D-5207FED5488F

P698

Q38174249-7FCF4742-AFF8-4A21-8D0C-747E519C85FD

P356

P1433

Liver International

P1476

Management of HCV transplant patients with triple therapy.

@en

P2093

Bruno Roche

http://www.w3.org/2001/XMLSchema#string

Jean-Charles Duclos-Vallée

http://www.w3.org/2001/XMLSchema#string

P2860

Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus

Drug-drug interactions during antiviral therapy for chronic hepatitis C

The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.

Host and donor risk factors before and after liver transplantation that impact HCV recurrence.

A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients.

Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis.

Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation.

PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus.

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.

P304

46-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/LIV.12406

http://www.w3.org/2001/XMLSchema#string

P478

34 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259489430

http://www.w3.org/2001/XMLSchema#string

P698

24373078

http://www.w3.org/2001/XMLSchema#string